Caballero, Editha R.
HRN: 22-86-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/10/2023
04/20/2023
IV
1.5gm
QID
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes